In summary, our study demonstrates that simultaneous inhibition of both HDAC1 and HDAC2 decreases the expression of BRCA1, CHK1, and RAD51, induces DNA DSBs and apoptosis, and abrogates cell cycle checkpoint activation induced by ara-C or DNR in AML cells. The gene discussed is CHEK1; the disease is acute myeloid leukemia.